Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Health Assembly

SEVENTIETH WORLD HEALTH ASSEMBLY A70/23 Add.2 Agenda item 13.6 25 May 2017 Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Health Assembly Decision: Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products A. Link to the general programme of work and programme budget 1. Outcome(s) in the Twelfth General Programme of Work, 2014–2019 and output(s) in the Programme budget 2016–2017 to which this decision would contribute if adopted. Twelfth General Programme of Work, 2014–2019 outcome(s): Improved access to, and rational use of, safe, efficacious and quality medicines and health technologies. Programme budget 2016–2017 output(s): Output 4.3.3. Improved quality and safety of medicines and other health technologies through norms, standards and guidelines, strengthening of regulatory systems, and prequalification. 2. Brief justification for considering the draft decision, if there is no link to the results as indicated in the Twelfth General Programme of Work, 2014–2019 and the Programme budget 2016–2017. Not applicable. 3. Estimated time frame (in years or months) for implementation of any additional deliverables. Three months (June–August 2017), if the decision is adopted by the Health Assembly. The WHO website would be updated: to reflect the endorsement of the definitions as set out in Appendix 3 to the Annex to document A70/23; and the term “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” would be replaced with “substandard and falsified medical products” in the name of the Member State Mechanism. B. Budgetary implications 1. Estimated total cost to implement the decision if adopted, in US$ millions: Zero cost implication. 2.a. Estimated additional budgetary requirements in the current biennium, in US$ millions: Zero cost implication. A70/23 Add.2 2 2.b. Resources available during the current biennium – Resources available in the current biennium to fund the implementation of the decision if adopted, in US$ millions: Zero cost implication. – Extent of any financing gap, in US$ millions: Not applicable. – Estimated resources, not yet available, which would help to close any financing gap, in US$ millions: Not applicable. 3. Estimated additional budgetary requirements in 2018–2019 (if relevant), in US$ millions: Zero cost implication. Has this been included in the Proposed programme budget 2018–2019? Not applicable. 4. Estimated additional budgetary requirements in future bienniums (if relevant), in US$ millions: Not applicable. = = =